Patterns in Medication Use for Treatment of Depression in Autistic Spectrum Disorder. Journal of Autism and Developmental Disorders. 2025; 55:1969-1975.
.Health Related Quality of Life in Autistic Youth and Their Families. Journal of Autism and Developmental Disorders. 2025; 55:1982-1987.
.Probing the Neurodynamic Mechanisms of Cognitive Flexibility in Depressed Individuals with Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. 2025; 35:231-243.
.Results from a Double-Blind, Randomized, Placebo-Controlled, Single-Dose, Crossover Trial of Lovastatin or Minocycline in Fragile X Syndrome. Journal of Child and Adolescent Psychopharmacology. 2025; 35:211-221.
.Accelerated Theta Burst Transcranial Magnetic Stimulation for Refractory Depression in Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. 2025; 55:940-954.
.Springer Nature; Springer Nature; 2025.
. Fragile X Syndrome. Neuropsychiatric Care for Genetic Syndromes and Other Neurodevelopmental Disorders. :Springer Nature; Springer Nature; 2025.
. Psychopharmacology in Autism. Handbook of Evidence-Based Practices in Autism Spectrum Disorder. :Dual Diagnosis of Fragile X Syndrome and DEPDC5-Related Disorder Emphasizes DEPDC5's Role Beyond Familial Epilepsy: A Case Report and Literature Review. Editor, Das SP. Case Reports in Genetics. 2025; 2025:4501466.
.(2024) Computer Vision Based Neurology Brain Activity Rejection Architecture and Implementation. Institute of Electrical and Electronics Engineers (IEEE). 00:1481-1487.
.Specialization of the brain for language in children with Fragile X Syndrome: a functional Near Infrared Spectroscopy study. Journal of Neurodevelopmental Disorders. 2024; 16:69.
.A near normal distribution of IQ in Fragile X Syndrome. Scientific Reports. 2024; 14:23058.
.Developmental milestones and daily living skills in individuals with Angelman syndrome. Journal of Neurodevelopmental Disorders. 2024; 16:32.
.Validating brain activity measures as reliable indicators of individual diagnostic group and genetically mediated sub-group membership Fragile X Syndrome. Scientific Reports. 2024; 14:22982.
.Innovative Approaches to Addressing Pediatric Mental Health. Pediatric Clinics of North America. 2024; 71:xvii-xix.
.Safety, Tolerability, and EEG-Based Target Engagement of STP1 (PDE3,4 Inhibitor and NKCC1 Antagonist) in a Randomized Clinical Trial in a Subgroup of Patients with ASD. Biomedicines. 2024; 12:1430.
.Editor, Chun SA; Talbert DA. 2024; 37.
. CNN Brain Label-Maker: Computer Vision Based ICA Rejection EEG based System Architecture.EEG Microstates as Markers for Cognitive Impairments in Fragile X Syndrome. Brain Topography: journal of functional neurophysiology. 2024; 37:432-446.
.Neurodevelopmental Disorders Including Autism Spectrum Disorder and Intellectual Disability as a Risk Factor for Delayed Diagnosis of Catatonia. Journal of Developmental and Behavioral Pediatrics. 2024; 45:e137-e142.
.Effects of AFQ056 on language learning in fragile X syndrome. The Journal of Clinical Investigation. 2024; 134:e171723.
.Latent Class Analysis Identifies Distinctive Behavioral Subtypes in Children with Fragile X Syndrome. Journal of Autism and Developmental Disorders. 2024; 54:725-737.
.Springer Nature; Springer Nature; 2024.
. From Kanner to DSM-V. Handbook of Early Intervention for Autism Spectrum Disorders. :Negative effect of treatment with mGluR5 negative allosteric modulator AFQ056 on blood biomarkers in young individuals with Fragile X syndrome. SAGE Open Medicine. 2024; 12:20503121241282401.
.Reliability of resting-state electrophysiology in fragile X syndrome. Biomarkers in Neuropsychiatry. 2023; 9:100070.
.Results of a phase Ib study of SB-121, an investigational probiotic formulation, a randomized controlled trial in participants with autism spectrum disorder. Scientific Reports. 2023; 13:5192.
.A sensitive and reproducible qRT-PCR assay detects physiological relevant trace levels of FMR1 mRNA in individuals with Fragile X syndrome. Scientific Reports. 2023; 13:3808.
.Hypersensitivity to Distractors in Fragile X Syndrome from Loss of Modulation of Cortical VIP Interneurons. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2023; 43:8172-8188.
.Genetic syndromes are prevalent in patients with comorbid neurodevelopmental disorders and catatonia. American Journal of Medical Genetics, Part A. 2023; 191:2716-2722.
.Developing improved outcome measures in FXS: Key stakeholder feedback. Research in Developmental Disabilities. 2023; 137:104502.
.Regulating Together: Emotion Dysregulation Group Treatment for ASD Youth and Their Caregivers. Journal of Autism and Developmental Disorders. 2023; 53:1942-1962.
.Behavioral inflexibility in fragile X syndrome: Accounts from caregivers and self-advocates. Frontiers in Psychology. 2023; 14:1118652.
.Neuropsychiatric feature-based subgrouping reveals neural sensory processing spectrum in female FMR1 premutation carriers: A pilot study. Frontiers in Integrative Neuroscience. 2023; 17:898215.
.Editorial: Precision medicine approaches for heterogeneous conditions such as autism spectrum disorders (The need for a biomarker exploration phase in clinical trials - Phase 2m). Frontiers in Psychiatry. 2023; 13:1079006.
.Parallel learning and cognitive flexibility impairments between Fmr1 knockout mice and individuals with fragile X syndrome. Frontiers in Behavioral Neuroscience. 2023; 16:1074682.
.Altered frontal connectivity as a mechanism for executive function deficits in fragile X syndrome. Molecular Autism. 2022; 13:47.
.Hemispheric Utilization of Alpha Oscillatory Dynamics as a Unique Biomarker of Neural Compensation in Females with Fragile X Syndrome. ACS Chemical Neuroscience. 2022; 13:3389-3402.
.Brief Report: Telehealth Satisfaction Among Caregivers of Pediatric and Adult Psychology and Psychiatry Patients with Intellectual and Developmental Disability in the Wake of Covid-19. Journal of Autism and Developmental Disorders. 2022; 52:5253-5265.
.A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX). Journal of Neurodevelopmental Disorders. 2022; 14:56.
.Optimization, validation and initial clinical implications of a Luminex-based immunoassay for the quantification of Fragile X Protein from dried blood spots. Scientific Reports. 2022; 12:5617.
.Baclofen-associated neurophysiologic target engagement across species in fragile X syndrome. Journal of Neurodevelopmental Disorders. 2022; 14:52.
.Neocortical localization and thalamocortical modulation of neuronal hyperexcitability contribute to Fragile X Syndrome. Communications Biology. 2022; 5:442.
.2022; 61:s275-s276.
. THALAMOCORTICAL DYSRHYTHMIA AS A UNIFYING MODEL OF NEUROPSYCHIATRIC AND NEUROSENSORY DYSFUNCTION IN FRAGILE X SYNDROME. Journal of the American Academy of Child and Adolescent Psychiatry.Observable Symptoms of Anxiety in Individuals with Fragile X Syndrome: Parent and Caregiver Perspectives. Genes. 2022; 13:1660.
.Integrating de novo and inherited variants in 42,607 autism cases identifies mutations in new moderate-risk genes. Nature Genetics. 2022; 54:1305-1319.
.Brief Report: Feasibility of the Probabilistic Reversal Learning Task as an Outcome Measure in an Intervention Trial for Individuals with Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. 2022; 52:4191-4199.
.A sound-driven cortical phase-locking change in the Fmr1 KO mouse requires Fmr1 deletion in a subpopulation of brainstem neurons. Neurobiology of Disease. 2022; 170:105767.
.Descriptive analysis of seizures and comorbidities associated with fragile X syndrome. Molecular Genetics and Genomic Medicine. 2022; 10:e2001.
.Children with ASD establish joint attention during free-flowing toy play without face looks. Current Biology. 2022; 32:2739-2746.e4.
.A Collaborative Psychiatric-Genetics Inpatient Care Delivery Model Improves Access to Clinical Genetic Evaluation, Testing, and Diagnosis for Patients With Neurodevelopmental Disorders. Frontiers in Genetics. 2022; 13:901458.
.A randomized double-blind, placebo-controlled pilot trial of mirtazapine for anxiety in children and adolescents with autism spectrum disorder. Neuropsychopharmacology. 2022; 47:1263-1270.
.Evidence for Three Subgroups of Female FMR1 Premutation Carriers Defined by Distinct Neuropsychiatric Features: A Pilot Study. Frontiers in Integrative Neuroscience. 2022; 15:797546.
.Seizures in Fragile X Syndrome: Associations and Longitudinal Analysis of a Large Clinic-Based Cohort. Frontiers in Pediatrics. 2021; 9:736255.
.Using head-mounted eye tracking to examine visual and manual exploration during naturalistic toy play in children with and without autism spectrum disorder. Scientific Reports. 2021; 11:3578.
.Psychotropic Drug Treatment Patterns in Persons with Fragile X Syndrome. Journal of Child and Adolescent Psychopharmacology. 2021; 31:659-669.
.Rare deleterious mutations of HNRNP genes result in shared neurodevelopmental disorders. Genome Medicine: medicine in the post-genomic era. 2021; 13:63.
.Decades of Progress in the Psychopharmacology of Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. 2021; 51:4370-4394.
.Brief Report: Impact of COVID-19 on Individuals with ASD and Their Caregivers: A Perspective from the SPARK Cohort. Journal of Autism and Developmental Disorders. 2021; 51:3766-3773.
.Letter to the Editor: Chlorpromazine-Induced Skin Pigmentation in a Pediatric Patient. Journal of Child and Adolescent Psychopharmacology. 2021; 31:516-517.
.Sex differences in resting EEG power in Fragile X Syndrome. Journal of Psychiatric Research. 2021; 138:89-95.
.Early Pandemic Experiences of Autistic Adults: Predictors of Psychological Distress. Autism Research: official journal of the International Society for Autism Research. 2021; 14:1209-1219.
.GABAA Alpha 2,3 Modulation Improves Select Phenotypes in a Mouse Model of Fragile X Syndrome. Frontiers in Psychiatry. 2021; 12:678090.
.Brief Report: Intranasal Ketamine in Adolescents and Young Adults with Autism Spectrum Disorder-Initial Results of a Randomized, Controlled, Crossover, Pilot Study. Journal of Autism and Developmental Disorders. 2021; 51:1392-1399.
.Can We Push the "Quasi-Perfect Artifact Rejection " Even Closer to Perfection?. Frontiers in Neuroinformatics. 2021; 14:597079.
.Springer Nature; Springer Nature; 2021.
. Mesoridazine. Encyclopedia of Autism Spectrum Disorders. :Springer Nature; Springer Nature; 2021.
. Thioridazine. Encyclopedia of Autism Spectrum Disorders. :Case Report: Is Catatonia a Clinical Feature of the Natural Progression of NLGN2-Related Neurodevelopmental Disorder?. Journal of Autism and Developmental Disorders. 2021; 51:371-376.
.Springer Nature; Springer Nature; 2021.
. Quetiapine. Encyclopedia of Autism Spectrum Disorders. :Springer Nature; Springer Nature; 2021.
. Alprazolam. Encyclopedia of Autism Spectrum Disorders. :Springer Nature; Springer Nature; 2021.
. Chlorpromazine. Encyclopedia of Autism Spectrum Disorders. :Springer Nature; Springer Nature; 2021.
. Antidepressant Medications. Encyclopedia of Autism Spectrum Disorders. :Springer Nature; Springer Nature; 2021.
. Clomipramine. Encyclopedia of Autism Spectrum Disorders. :Springer Nature; Springer Nature; 2021.
. Abnormal Involuntary Movement Scale. Encyclopedia of Autism Spectrum Disorders. :Springer Nature; Springer Nature; 2021.
. Sertraline. Encyclopedia of Autism Spectrum Disorders. :Springer Nature; Springer Nature; 2021.
. Serotonin Syndrome. Encyclopedia of Autism Spectrum Disorders. :Springer Nature; Springer Nature; 2021.
. Thiothixene. Encyclopedia of Autism Spectrum Disorders. :Springer Nature; Springer Nature; 2021.
. Aripiprazole. Encyclopedia of Autism Spectrum Disorders. :Springer Nature; Springer Nature; 2021.
. Atypical Antipsychotics. Encyclopedia of Autism Spectrum Disorders. :Springer Nature; Springer Nature; 2021.
. Nortriptyline. Encyclopedia of Autism Spectrum Disorders. :Springer Nature; Springer Nature; 2021.
. Serotonin Reuptake Inhibitors (SRIs). Encyclopedia of Autism Spectrum Disorders. :